419 related articles for article (PubMed ID: 37509339)
1. Decoding Oncofusions: Unveiling Mechanisms, Clinical Impact, and Prospects for Personalized Cancer Therapies.
Salokas K; Dashi G; Varjosalo M
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509339
[TBL] [Abstract][Full Text] [Related]
2. Oncofusions - shaping cancer care.
Dashi G; Varjosalo M
Oncologist; 2024 Jun; ():. PubMed ID: 38833619
[TBL] [Abstract][Full Text] [Related]
3. Human transcription factor and protein kinase gene fusions in human cancer.
Salokas K; Weldatsadik RG; Varjosalo M
Sci Rep; 2020 Aug; 10(1):14169. PubMed ID: 32843691
[TBL] [Abstract][Full Text] [Related]
4. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
5. The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations.
Kinnunen M; Liu X; Niemelä E; Öhman T; Gawriyski L; Salokas K; Keskitalo S; Varjosalo M
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686522
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Molecular events in follicular thyroid tumors.
Kroll TG
Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. Discovering chromatin dysregulation induced by protein-coding perturbations at scale.
Frenkel M; Hujoel MLA; Morris Z; Raman S
bioRxiv; 2023 Sep; ():. PubMed ID: 37781603
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
[TBL] [Abstract][Full Text] [Related]
12. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
13. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
14. Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management.
Srivastava S; Jayaswal N; Kumar S; Sharma PK; Behl T; Khalid A; Mohan S; Najmi A; Zoghebi K; Alhazmi HA
Cell Signal; 2024 Jan; 113():110932. PubMed ID: 37866667
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
16. Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.
Xiao X; Garbutt CC; Hornicek F; Guo Z; Duan Z
Cancer Treat Rev; 2018 Feb; 63():61-70. PubMed ID: 29247978
[TBL] [Abstract][Full Text] [Related]
17. Identification of fusion genes in breast cancer by paired-end RNA-sequencing.
Edgren H; Murumagi A; Kangaspeska S; Nicorici D; Hongisto V; Kleivi K; Rye IH; Nyberg S; Wolf M; Borresen-Dale AL; Kallioniemi O
Genome Biol; 2011; 12(1):R6. PubMed ID: 21247443
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma Insights: Established Foundations and Cutting-Edge Innovations from Dr. James Cleary's Pioneering Research.
Cortiana V; Chorya H; Joshi M; Kannan S; Mahendru D; Vallabhaneni H; Coloma HS; Leyfman Y; Park CH
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339383
[TBL] [Abstract][Full Text] [Related]
19. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
20. Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets.
Karagiannakos A; Adamaki M; Tsintarakis A; Vojtesek B; Fåhraeus R; Zoumpourlis V; Karakostis K
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
